Global Stem Cell Therapy Market Professional Survey Report 2016
- QYR587935
- 106 Pages
- June 2016
- Diagnostic and Biotech
Mainly covers the following product types
Autologous
Allogeneic
The segment applications including
CNS
CVS
GIT
Wounds and Injuries
Musculoskeletal
Eye
Immune System
Others
Segment regions including (the separated region report can also be offered)
North America
Europe
China
Japan
Latin America
Southeast Asia
India
The players list (Partly, Players you are interested in can also be added)
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Celgene
Guanhao Biotech
Mesoblast
Vericel Corporation
Stemcell Technologes
Beike Biotechnology
Cytori Therapeutics
Bioheart
Athersys
Geron
Pluristem Therapeutics
Fibrocell Science
Ocata Therapeutics
With no less than 15 top producers.
Data including (both global and regions): Market Size (both volume - and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - , Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 Industry Overview of Stem Cell Therapy
1.1 Definition and Specifications of Stem Cell Therapy
1.1.1 Definition of Stem Cell Therapy
1.1.2 Specifications of Stem Cell Therapy
1.2 Classification of Stem Cell Therapy
1.2.1 Autologous
1.2.2 Allogeneic
1.3 Applications of Stem Cell Therapy
1.3.1 CNS
1.3.2 CVS
1.3.3 GIT
1.3.4 Wounds and Injuries
1.3.5 Musculoskeletal
1.3.6 Eye
1.3.7 Immune System
1.3.8 Others
1.4 Industry Chain Structure of Stem Cell Therapy
1.5 Industry Overview and Major Regions Status of Stem Cell Therapy
1.5.1 Industry Overview of Stem Cell Therapy
1.5.2 Global Major Regions Status of Stem Cell Therapy
1.6 Industry Policy Analysis of Stem Cell Therapy
1.7 Industry News Analysis of Stem Cell Therapy
2 Manufacturing Cost Structure Analysis of Stem Cell Therapy
2.1 Raw Material Suppliers and Price Analysis of Stem Cell Therapy
2.2 Equipment Suppliers and Price Analysis of Stem Cell Therapy
2.3 Labor Cost Analysis of Stem Cell Therapy
2.4 Other Costs Analysis of Stem Cell Therapy
2.5 Manufacturing Cost Structure Analysis of Stem Cell Therapy
2.6 Manufacturing Process Analysis of Stem Cell Therapy
3 Technical Data and Manufacturing Plants Analysis of Stem Cell Therapy
3.1 Capacity and Commercial Production Date of Global Stem Cell Therapy Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Stem Cell Therapy Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Stem Cell Therapy Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Stem Cell Therapy Major Manufacturers in 2015
4 Global Stem Cell Therapy Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Stem Cell Therapy Capacity and Growth Rate Analysis
4.2.2 2015 Stem Cell Therapy Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Stem Cell Therapy Sales and Growth Rate Analysis
4.3.2 2015 Stem Cell Therapy Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Stem Cell Therapy Sales Price
4.4.2 2015 Stem Cell Therapy Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Stem Cell Therapy Gross Margin
4.5.2 2015 Stem Cell Therapy Gross Margin Analysis (Company Segment)
5 Stem Cell Therapy Regional Market Analysis
5.1 North America Stem Cell Therapy Market Analysis
5.1.1 North America Stem Cell Therapy Market Overview
5.1.2 North America 2011-2016E Stem Cell Therapy Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E Stem Cell Therapy Sales Price Analysis
5.1.4 North America 2015 Stem Cell Therapy Market Share Analysis
5.2 Europe Stem Cell Therapy Market Analysis
5.2.1 Europe Stem Cell Therapy Market Overview
5.2.2 Europe 2011-2016E Stem Cell Therapy Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2011-2016E Stem Cell Therapy Sales Price Analysis
5.2.4 Europe 2015 Stem Cell Therapy Market Share Analysis
5.3 China Stem Cell Therapy Market Analysis
5.3.1 China Stem Cell Therapy Market Overview
5.3.2 China 2011-2016E Stem Cell Therapy Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China 2011-2016E Stem Cell Therapy Sales Price Analysis
5.3.4 China 2015 Stem Cell Therapy Market Share Analysis
5.4 Japan Stem Cell Therapy Market Analysis
5.4.1 Japan Stem Cell Therapy Market Overview
5.4.2 Japan 2011-2016E Stem Cell Therapy Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2011-2016E Stem Cell Therapy Sales Price Analysis
5.4.4 Japan 2015 Stem Cell Therapy Market Share Analysis
5.5 Latin America Stem Cell Therapy Market Analysis
5.5.1 Latin America Stem Cell Therapy Market Overview
5.5.2 Latin America 2011-2016E Stem Cell Therapy Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Latin America 2011-2016E Stem Cell Therapy Sales Price Analysis
5.5.4 Latin America 2015 Stem Cell Therapy Market Share Analysis
5.6 Southeast Asia Stem Cell Therapy Market Analysis
5.6.1 Southeast Asia Stem Cell Therapy Market Overview
5.6.2 Southeast Asia 2011-2016E Stem Cell Therapy Local Supply, Import, Export, Local Consumption Analysis
5.6.3 Southeast Asia 2011-2016E Stem Cell Therapy Sales Price Analysis
5.6.4 Southeast Asia 2015 Stem Cell Therapy Market Share Analysis
5.7 India Stem Cell Therapy Market Analysis
5.7.1 India Stem Cell Therapy Market Overview
5.7.2 India 2011-2016E Stem Cell Therapy Local Supply, Import, Export, Local Consumption Analysis
5.7.3 India 2011-2016E Stem Cell Therapy Sales Price Analysis
5.7.4 India 2015 Stem Cell Therapy Market Share Analysis
6 Global 2011-2016E Stem Cell Therapy Segment Market Analysis (by Type)
6.1 Global 2011-2016E Stem Cell Therapy Sales by Type
6.2 Different Types Stem Cell Therapy Product Interview Price Analysis
6.3 Different Types Stem Cell Therapy Product Driving Factors Analysis
6.3.1 Autologous Stem Cell Therapy Growth Driving Factor Analysis
6.3.2 Allogeneic Stem Cell Therapy Growth Driving Factor Analysis
7 Global 2011-2016E Stem Cell Therapy Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 CNS Stem Cell Therapy Growth Driving Factor Analysis
7.3.2 CVS Stem Cell Therapy Growth Driving Factor Analysis
7.3.3 GIT Stem Cell Therapy Growth Driving Factor Analysis
7.3.4 Wounds and Injuries Stem Cell Therapy Growth Driving Factor Analysis
7.3.5 Musculoskeletal Stem Cell Therapy Growth Driving Factor Analysis
7.3.6 Eye Stem Cell Therapy Growth Driving Factor Analysis
7.3.7 Immune System Stem Cell Therapy Growth Driving Factor Analysis
7.3.8 Others Stem Cell Therapy Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Stem Cell Therapy
8.1 Cellular Dynamics International
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 Cellular Dynamics International 2015 Stem Cell Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Cellular Dynamics International 2015 Stem Cell Therapy Business Region Distribution Analysis
8.2 Osiris Therapeutics
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Osiris Therapeutics 2015 Stem Cell Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Osiris Therapeutics 2015 Stem Cell Therapy Business Region Distribution Analysis
8.3 Vcanbio
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Vcanbio 2015 Stem Cell Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Vcanbio 2015 Stem Cell Therapy Business Region Distribution Analysis
8.4 Gamida Cell
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Gamida Cell 2015 Stem Cell Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Gamida Cell 2015 Stem Cell Therapy Business Region Distribution Analysis
8.5 Golden Meditech
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Golden Meditech 2015 Stem Cell Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Golden Meditech 2015 Stem Cell Therapy Business Region Distribution Analysis
8.6 Celgene
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Celgene 2015 Stem Cell Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Celgene 2015 Stem Cell Therapy Business Region Distribution Analysis
8.7 Guanhao Biotech
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Guanhao Biotech 2015 Stem Cell Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Guanhao Biotech 2015 Stem Cell Therapy Business Region Distribution Analysis
8.8 Mesoblast
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Mesoblast 2015 Stem Cell Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Mesoblast 2015 Stem Cell Therapy Business Region Distribution Analysis
8.9 Vericel Corporation
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Vericel Corporation 2015 Stem Cell Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Vericel Corporation 2015 Stem Cell Therapy Business Region Distribution Analysis
8.10 Stemcell Technologes
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Stemcell Technologes 2015 Stem Cell Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Stemcell Technologes 2015 Stem Cell Therapy Business Region Distribution Analysis
8.11 Beike Biotechnology
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Beike Biotechnology 2015 Stem Cell Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Beike Biotechnology 2015 Stem Cell Therapy Business Region Distribution Analysis
8.12 Cytori Therapeutics
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Cytori Therapeutics 2015 Stem Cell Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Cytori Therapeutics 2015 Stem Cell Therapy Business Region Distribution Analysis
8.13 Bioheart
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Bioheart 2015 Stem Cell Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Bioheart 2015 Stem Cell Therapy Business Region Distribution Analysis
8.14 Athersys
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 Athersys 2015 Stem Cell Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Athersys 2015 Stem Cell Therapy Business Region Distribution Analysis
8.15 Geron
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Geron 2015 Stem Cell Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Geron 2015 Stem Cell Therapy Business Region Distribution Analysis
8.16 Pluristem Therapeutics
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Pluristem Therapeutics 2015 Stem Cell Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Pluristem Therapeutics 2015 Stem Cell Therapy Business Region Distribution Analysis
8.17 Fibrocell Science
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Fibrocell Science 2015 Stem Cell Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Fibrocell Science 2015 Stem Cell Therapy Business Region Distribution Analysis
8.18 Ocata Therapeutics
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 Ocata Therapeutics 2015 Stem Cell Therapy Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 Ocata Therapeutics 2015 Stem Cell Therapy Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 North America 2016-2021 Stem Cell Therapy Consumption Forecast
9.2.2 Europe 2016-2021 Stem Cell Therapy Consumption Forecast
9.2.3 China 2016-2021 Stem Cell Therapy Consumption Forecast
9.2.4 Japan 2016-2021 Stem Cell Therapy Consumption Forecast
9.2.5 Latin America 2016-2021 Stem Cell Therapy Consumption Forecast
9.2.6 Southeast Asia 2016-2021 Stem Cell Therapy Consumption Forecast
9.2.7 India 2016-2021 Stem Cell Therapy Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Stem Cell Therapy Marketing Model Analysis
10.1 Stem Cell Therapy Regional Marketing Model Analysis
10.2 Stem Cell Therapy International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Stem Cell Therapy by Regions
10.4 Stem Cell Therapy Supply Chain Analysis
11 Consumers Analysis of Stem Cell Therapy
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of Stem Cell Therapy
12.1 New Project SWOT Analysis of Stem Cell Therapy
12.2 New Project Investment Feasibility Analysis of Stem Cell Therapy
13 Conclusion of the Global Stem Cell Therapy Market Professional Survey Report 2016
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
